EBD GmbH is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BioPharm America 2014 EBD Group MassBio
Share/Follow Us
Share this:
Follow this event:

BioPharm America™ 2016 Press Releases

News for BioPharm America™ 2016 will be available soon.

September 24, 2015BioPharm America™ 2015 convenes over 800 global life science investors, leaders in Boston The eighth edition of BioPharm America 2015 life science partnering event wrapped up last week in Boston with overwhelming success. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the event brought together cutting edge biotech companies and early stage startups, with executives from global pharmaceutical companies, finance, invest...  more ►

September 16, 2015Best of Boston biotech startups win recognition at BioPharm America™ 2015 during Johnson & Johnson Innovation Startup Day competition EBD Group today announced the winners of the first annual Johnson & Johnson Innovation Biotech Startup Day competition at the eighth annual BioPharm America 2015 life science partnering event in Boston. The winner of the Johnson & Johnson Innovation Startup Day competition grand prize went to Proteorex Therapeutics Inc. for their innovative technology and services t...  more ►

September 2, 2015EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm America™ 2015 Partnering EventLeaders in life sciences to gather in Boston September 15–17 for partnering event
September 2, 2015: BioPharm America 2015 life science partnering event will take place in Boston September 15–17 at the Boston Marriott Copley Place. The event will convene members of the global life science community to forge connections among startups, entrepreneurs and the drug development industry. A pitch contest for startup and young companies will take place in ...  more ►

July 22, 2015BioPharm America™ 2015 to bring industry heavy hitters and biotech disruptors to Boston September 15–17 BioPharm America 2015 will once again bring the most talented, innovative leaders of biotech and pharma to Boston this September 15–17 at the Boston Marriott Copley Place. An increasing number of industry heavy hitters have successfully led and exited large corporations and are now investing their experience, clout and personal finances to reseed the life science ecosy...  more ►

June 9, 2015Spotlight on Boston Business Facts The life sciences corridor in Massachusetts combines the cities of Somerville, Cambridge, Boston, Quincy and Braintree, and is home to over 450 companies within the life science industry cluster. There were USD 1,802 billion of venture investments in Massachusetts biotechs in 2014. Massachusetts has seen 30 companies go public in the last two years. Some of the largest bio...  more ►

May 20, 2015Engage and De-Risk: BioPharm America™ 2015 draws life science dealmaking ecosystem to Boston this September 15–17 EBD Group and MassBio present the eighth annual BioPharm America international life science partnering conference September 15–17 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings executives from the life science ecosystem together to de-risk the environment inherent to biotech and engage in disruptive dealmaking. BioPharm Am...  more ►


partnering360® Blog

February 8, 2016 Top 10 Digital Health Trends: Implications for Early to Mid-Stage Biopharma Guest post by Jay Goldman (Managing Director, Sensei Labs at Klick Health) and Michael W. Young (VP, Strategy at Klick Health) We recently had the pleasure of presenting on the Top 10 Digital Health Trends at Biotech Showcase™ 2016’s inaugural Digital Health Showcase. Our highly engaged audience... more ►

February 4, 2016 Can biology, even drug discovery, be “clouded”? It’s early but Andreessen Horowitz VC thinks so Digital health is not just a buzzword in the life science industry; it is an innovative, potentially disruptive, health paradigm that is gaining momentum. At Digital Health Showcase in January, CBT Advisors’ Steve Dickman met with Vijay Pande of Andreessen Horowitz, a renowned professor formerly... more ►

February 2, 2016 Where you build your healthcare IP is just as important as how you build it Guest post by Ben Ball, Business Development Manager, Australian Consulate-General   For most businesses, intellectual property is the foundation you build on. Transforming an idea into a product is only half the battle—the way you take that product to market may ultimately play a larger part... more ►

January 27, 2016 Why do we believe in Nordic life science? Guest post by Anna Sandström, Science Relations Director, AstraZeneca   While my high-speed train whirls its way across the broadest part of Sweden, from Gothenburg to Stockholm I am finishing my dinner, and as I lift the glass I once again start to philosophize about why some people tend to... more ►

January 22, 2016 Golden Ticket winner represents partnering opportunities with academia   We are proud to have sponsored the Circus before the Circus networking reception at the Four Seasons Hotel on January 10 during healthcare’s busiest week in San Francisco. Biotech Showcase™ 2016 investor and networking conference—the event where innovation meets money—broke records... more ►



partnering360:Insight Latest headlines from partnering360:Insight

February 9, 2016 Partnering Spotlight: Jiangsu Hengrui Medicine In September 2015, Jiangsu Hengrui Medicine made history by out-licensing global rights (not including China) to its PD-1 cancer immunotherapy. Incyte, a US oncology pharma, acquired the rights in a deal worth up to USD 795 million if Hengrui collects all the milestones, the largest amount ever paid for a single China pharma asset. more ►

January 19, 2016 Digital Health Showcase: State of the Industry Report Digital health is a young, vibrant industry with great potential. Now, after five years of buzz, it’s beginning to deliver on that potential with opportunities for drug developers, clinicians and patients, according to speakers at Digital Health Showcase, held in conjunction with Biotech Showcase™ 2016 January 13 in San Francisco. more ►

January 19, 2016 Bubble trouble? Investors advise cautious optimism Biotech still outperforms the S&P, attracts new investors and has a healthy pipeline. The fundamentals are still there. That’s why investment veterans speaking at the Biotech Showcase 2016 luncheon plenary January 13 in San Francisco remain optimistic despite advising CEOs to prepare for a downturn. more ►

January 19, 2016 Digital health and big pharma: A tale of two companies Digital health strategies have the potential to increase patient compliance and monitor and manage disease progression. For big pharma, they offer a way to improve patient experiences and gain deeper insights that may support outcomes-based pricing, according to experts from Novartis and Takeda Pharmaceuticals International, speaking at Digital Health Showcase January 13, held concurrently with Biotech Showcase™ 2016 in San Francisco. more ►

January 13, 2016 Medtech Showcase: State of the Industry 2016 Healthcare is converging, bringing together traditional therapeutics, precision medicine, combination products and companion diagnostics that require insightful approval and reimbursement policies. It also requires that entrepreneurs develop a keen understanding of what drives their potential markets, according to speakers at Medtech Showcase, held January 12 in San Francisco in concert with Biotech Showcase 2016. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group, Inc.
Privacy Policy and Cookies
Terms of Use